Shu-fen Chen

No. 12, Wulumuqi Road
Jing'an, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Journal: Brain : a journal of neurology

Published: January 26, 2026

Plasma p-Tau217 improves diagnostic accuracy and clinician confidence in cognitive disorder classification.

Plasma p-Tau217 improves diagnostic accuracy and clinician confidence in cognitive disorder classification.

Journal: Innovation (Cambridge (Mass.))

Published: October 10, 2025

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Journal: Brain : a journal of neurology

Published: August 14, 2025

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Journal: Brain : a journal of neurology

Published: August 14, 2025

Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson's disease.

Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson's disease.

Journal: Science (New York, N.Y.)

Published: February 20, 2025

Role of 18F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment.

Role of 18F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 06, 2025

Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti-LGI1 Antibody Encephalitis: A Multicenter Cohort Study.

Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti-LGI1 Antibody Encephalitis: A Multicenter Cohort Study.

Journal: CNS neuroscience & therapeutics

Published: January 16, 2025

Clinical utility of cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic workup of complex patients with cognitive impairment.

Clinical utility of cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic workup of complex patients with cognitive impairment.

Journal: Translational psychiatry

Published: September 30, 2024

Clinical, radiological, pathological and prognostic features of general paresis: a cohort study.

Clinical, radiological, pathological and prognostic features of general paresis: a cohort study.

Journal: Brain : a journal of neurology

Published: July 17, 2024

The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.

The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.

Journal: Journal of Alzheimer's disease : JAD

Published: June 07, 2024

Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework.

Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework.

Journal: CNS neuroscience & therapeutics

Published: February 12, 2024

Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer's disease.

Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 13, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026